Jason Valent, MD, Director of the Multiple Myeloma Program and Co-Director of the Amyloidosis Program at Cleveland Clinic Cancer Center, joins the Cancer Advances podcast to discuss the developments of the CAEL-101 trial for patients with AL amyloidosis. Listen as Dr. Valent talks about the discoveries and changes in treatment in each phase of the trial.